MVZ Leverkusen

MVZ Leverkusen gGmbH is a multi-disciplinary medical center in Leverkusen, Germany, providing a wide array of healthcare services. The center is dedicated to improving patient health outcomes and ensuring accessible medical care for the community. MVZ Leverkusen gGmbH operates as a comprehensive medical center offering various healthcare services. The company was acquired by Synlab, a portfolio company of BC Partners, in January 2010.

The facility is located in Leverkusen, Germany, which serves as its headquarters. Andreas Weiß leads the organization as CEO. MVZ Leverkusen gGmbH operates as a multi-disciplinary medical center offering a comprehensive range of healthcare services designed to address various medical needs within the community. Key service offerings include general medicine, obstetrics, gynecology, internal medicine, pediatrics, prenatal medicine, and pain therapy.

The facility houses a team of specialized practitioners, including Dr. Cathrin Bahl and Dr. Helena Pavlakovic, who provide pediatric care, and Dr. Judith Hennecken, who specializes in hematology and oncology.

These services aim to improve patient health outcomes and ensure accessible medical care for families and individuals across Langenfeld and the surrounding regions. In the year 2021, MVZ Leverkusen gGmbH reported a revenue of EUR 3. 31 mn and an EBITDA of EUR 135,957, indicating its financial performance in the healthcare market. The revenue model primarily revolves around direct patient transactions for medical services rendered, with patients engaging through appointments for consultations, examinations, and treatments.

The medical center may also participate in insurance partnerships, where reimbursement occurs through health insurers for services rendered to insured patients. While specific upcoming products or services were not mentioned, MVZ Leverkusen gGmbH's strategic focus remains on delivering quality healthcare services. The acquisition by Synlab in January 2010 indicates a potential for integration into broader health service offerings, which may support growth initiatives. Plans for expanding into new markets or regions were not specified, but the company's existing services cater primarily to patients in Germany.